Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
Status:
Recruiting
Trial end date:
2028-11-30
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find a recommended dose of donated NK cells
that can be given along with chemotherapy to patients with advanced cancers. The safety and
effects of this therapy will also be studied.